Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turkey
Davran Çiçek(Başkent University), Haldun Müderrisoğlu(Başkent University), Süleyman Binici(Başkent University), Haşan Pekdemir(Inonu University), Nihat Kalay(Erciyes University), Hakan Altay(Başkent University), Cevahir Haberal(Başkent University)
Cited by 3
Related Papers
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
|Journal of the American College of Cardiology|2006|715
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
|International Journal of Cardiology|2012|325
Protective Effects of Spironolactone Against Anthracycline-Induced Cardiomyopathy
|European Journal of Heart Failure|2014|259
Cardiovascular Effects of Carbon Monoxide Poisoning
|The American Journal of Cardiology|2006|141